Skip to main content
Skip to footer
Menu
Who We Are
Our Focus : Mitral Regurgitation
Our TSMVR Solution
News
Contact
fr
Press releases
Press releases
Events
Media
HighLife Receives ISO 13485 Certification of its Quality Management System
HighLife welcomes Stefan Pilz as new Chief Executive Officer
HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation
HighLife appoints Prof. Stephen Brecker Chief Medical Officer
HighLife launches a new Large Annulus Valve in ongoing clinical studies for patients suffering from Mitral Regurgitation
HighLife’s TSMVR Technology successfully used for the first time in China
HighLife’s TSMVR System and Clinical Study progress featured at EuroPCR 2021
Peijia Medical and HighLife Enter Into a License and Technology Transfer Agreement for Trans-septalMitral Valve Replacement in Greater China
1
2
Top